Royalty Pharma plc Peer Comparison
Metric | Value | Ranking | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $14.0 Billion | 2/18 | BGNE $20.2B |
RPRX $14.0B |
KRTX $12.6B |
ASND $8.6B |
MDGL $7.4B |
BPMC $6.0B |
ISEE $5.5B |
MRTX $4.1B |
APLS $3.4B |
IOVA $1.7B |
DAWN $1.2B |
ADPT $1.2B |
DNA $846.7M |
CVAC $818.7M |
KNTE $125.0M |
RPHM $60.8M |
IKNA $60.0M |
OCEA $4.5M |
Gross Margin | 100% | 1/18 | RPRX 100% |
BPMC 98% |
MDGL 97% |
CVAC 96% |
ASND 92% |
DAWN 92% |
MRTX 91% |
DNA 89% |
BGNE 83% |
APLS 81% |
ADPT 64% |
IOVA 32% |
ISEE 0% |
KRTX 0% |
KNTE 0% |
IKNA 0% |
RPHM 0% |
OCEA 0% |
Profit Margin | 35% | 3/18 | DAWN 100% |
CVAC 68% |
RPRX 35% |
ISEE 0% |
KRTX 0% |
KNTE 0% |
IKNA 0% |
RPHM 0% |
OCEA 0% |
BGNE -12% |
ASND -22% |
APLS -33% |
BPMC -44% |
DNA -63% |
ADPT -69% |
MRTX -100% |
IOVA -100% |
MDGL -100% |
EBITDA margin | 61% | 3/18 | DAWN 148% |
CVAC 76% |
RPRX 61% |
BGNE -5% |
ASND -22% |
BPMC -26% |
APLS -38% |
DNA -62% |
ADPT -70% |
ISEE -100% |
KRTX -100% |
KNTE -100% |
IKNA -100% |
RPHM -100% |
OCEA -100% |
IOVA -152% |
MDGL -166% |
MRTX -1049% |
Quarterly Revenue | $594.0 Million | 2/18 | BGNE $1.0B |
RPRX $594.0M |
CVAC $542.7M |
ASND $191.1M |
APLS $176.6M |
BPMC $128.2M |
DNA $89.0M |
MDGL $62.2M |
IOVA $58.6M |
ADPT $46.4M |
DAWN $20.1M |
MRTX $16.4M |
ISEE $0 |
KRTX $0 |
KNTE $0 |
IKNA $0 |
RPHM $0 |
OCEA $0 |
Quarterly Earnings | $208.0 Million | 2/18 | CVAC $371.5M |
RPRX $208.0M |
DAWN $37.0M |
RPHM -$5.4M |
OCEA -$5.5M |
IKNA -$10.2M |
KNTE -$17.1M |
ADPT -$32.1M |
ASND -$42.3M |
BPMC -$56.3M |
DNA -$56.4M |
APLS -$57.4M |
ISEE -$70.6M |
IOVA -$83.5M |
MDGL -$107.0M |
KRTX -$113.8M |
BGNE -$121.4M |
MRTX -$161.9M |
Quarterly Free Cash Flow | $743.0 Million | 1/18 | RPRX $743.0M |
CVAC $385.5M |
BGNE $54.7M |
APLS $34.1M |
RPHM -$0 |
OCEA -$885,000 |
DAWN -$5.0M |
IKNA -$8.9M |
BPMC -$13.7M |
KNTE -$17.4M |
ADPT -$27.4M |
ISEE -$50.8M |
IOVA -$61.3M |
MDGL -$62.8M |
ASND -$96.2M |
KRTX -$111.9M |
DNA -$118.6M |
MRTX -$143.7M |
Trailing 4 Quarters Revenue | $2.3 Billion | 2/18 | BGNE $3.3B |
RPRX $2.3B |
APLS $675.9M |
CVAC $596.5M |
BPMC $434.4M |
ASND $399.8M |
DNA $218.0M |
ADPT $177.3M |
IOVA $90.9M |
MDGL $76.8M |
MRTX $38.2M |
DAWN $28.8M |
RPHM $734,000 |
IKNA $659,000 |
KRTX $654,000 |
ISEE $0 |
KNTE $0 |
OCEA $0 |
Trailing 4 Quarters Earnings | $858.8 Million | 1/18 | BGNE $1.0B |
RPRX $594.0M |
CVAC $542.7M |
ASND $191.1M |
APLS $176.6M |
BPMC $128.2M |
DNA $89.0M |
MDGL $62.2M |
IOVA $58.6M |
ADPT $46.4M |
DAWN $20.1M |
MRTX $16.4M |
ISEE -$0 |
KRTX -$0 |
KNTE -$0 |
IKNA -$0 |
RPHM -$0 |
OCEA -$0 |
Quarterly Earnings Growth | -58% | 16/18 | CVAC 794% |
DAWN 180% |
DNA 81% |
RPHM 73% |
OCEA 61% |
APLS 59% |
BPMC 58% |
ASND 56% |
KNTE 43% |
IKNA 41% |
ADPT 36% |
IOVA 27% |
MRTX 7% |
MDGL -8% |
KRTX -49% |
RPRX -58% |
ISEE -104% |
BGNE -156% |
Annual Earnings Growth | 21% | 7/18 | CVAC 144% |
BPMC 76% |
APLS 51% |
OCEA 50% |
DAWN 50% |
ASND 34% |
RPRX 21% |
DNA 21% |
IKNA 13% |
KNTE 9% |
RPHM 9% |
BGNE 7% |
IOVA 5% |
ADPT -1% |
MRTX -2% |
KRTX -37% |
MDGL -46% |
ISEE -60% |
Quarterly Revenue Growth | 0% | 10/18 | IOVA 12385% |
CVAC 2896% |
MRTX 202% |
BPMC 127% |
APLS 78% |
DNA 61% |
BGNE 28% |
ASND 26% |
ADPT 22% |
RPRX 0% |
MDGL 0% |
ISEE 0% |
KNTE 0% |
IKNA 0% |
RPHM 0% |
OCEA 0% |
DAWN 0% |
KRTX -100% |
Annual Revenue Growth | 3% | 8/18 | IOVA 7580% |
CVAC 1284% |
BPMC 89% |
MRTX 77% |
APLS 76% |
BGNE 29% |
ASND 29% |
RPRX 3% |
MDGL 0% |
ISEE 0% |
KNTE 0% |
RPHM 0% |
OCEA 0% |
DAWN 0% |
ADPT -4% |
DNA -27% |
KRTX -88% |
IKNA -89% |
Cash On Hand | $929.0 Million | 2/18 | BGNE $2.7B |
RPRX $929.0M |
DNA $616.2M |
ASND $614.9M |
CVAC $605.3M |
ISEE $467.6M |
DAWN $422.8M |
APLS $396.9M |
MRTX $258.7M |
MDGL $232.7M |
KRTX $185.8M |
IOVA $164.2M |
BPMC $89.4M |
KNTE $57.0M |
IKNA $45.2M |
ADPT $38.1M |
RPHM $36.0M |
OCEA -$0 |
Short Term Debt | $0 | 17/18 | BGNE $881.5M |
ASND $540.1M |
BPMC $45.0M |
OCEA $12.8M |
IOVA $11.6M |
ADPT $10.0M |
MRTX $8.0M |
APLS $6.8M |
CVAC $5.7M |
IKNA $3.9M |
KRTX $2.8M |
KNTE $892,000 |
MDGL $878,000 |
ISEE $774,000 |
RPHM $331,000 |
DAWN $77,000 |
RPRX -$0 |
DNA -$0 |
Long Term Debt | $0 | 16/18 | DNA $445.6M |
ASND $401.2M |
BPMC $341.5M |
BGNE $220.0M |
MDGL $118.3M |
APLS $104.7M |
ISEE $97.0M |
ADPT $81.8M |
IOVA $66.4M |
MRTX $42.2M |
CVAC $38.3M |
KRTX $13.8M |
IKNA $4.5M |
DAWN $2.5M |
RPHM $492,000 |
RPRX $0 |
KNTE $0 |
OCEA $0 |
PE | 16.33 | 1/18 | RPRX 16.33 |
CVAC 6.76 |
BGNE -1.00 |
MRTX -1.00 |
IOVA -1.00 |
MDGL -1.00 |
BPMC -1.00 |
APLS -1.00 |
ASND -1.00 |
ADPT -1.00 |
ISEE -1.00 |
KRTX -1.00 |
KNTE -1.00 |
IKNA -1.00 |
RPHM -1.00 |
OCEA -1.00 |
DAWN -1.00 |
DNA -1.00 |
PS | 6.19 | 11/18 | KRTX 19264.95 |
MRTX 107.82 |
MDGL 95.75 |
IKNA 91.02 |
RPHM 82.89 |
DAWN 42.90 |
ASND 19.63 |
IOVA 18.68 |
BPMC 13.82 |
ADPT 6.93 |
RPRX 6.19 |
BGNE 6.09 |
APLS 5.04 |
DNA 3.88 |
CVAC 1.25 |
ISEE -1.00 |
KNTE -1.00 |
OCEA -1.00 |
PB | 1.36 | 11/18 | BPMC 19.17 |
APLS 14.37 |
ISEE 11.55 |
KRTX 10.05 |
MDGL 9.46 |
BGNE 5.88 |
ADPT 5.50 |
MRTX 4.35 |
DAWN 2.23 |
IOVA 2.19 |
RPRX 1.36 |
DNA 1.06 |
CVAC 1.03 |
RPHM 0.79 |
KNTE 0.78 |
IKNA 0.45 |
ASND 0.00 |
OCEA 0.00 |
PC | 15.09 | 6/18 | KRTX 67.80 |
BPMC 67.18 |
ADPT 32.28 |
MDGL 31.61 |
MRTX 15.92 |
RPRX 15.09 |
ASND 14.02 |
ISEE 11.79 |
IOVA 10.34 |
APLS 8.59 |
BGNE 7.48 |
DAWN 2.92 |
KNTE 2.19 |
RPHM 1.69 |
DNA 1.37 |
CVAC 1.35 |
IKNA 1.33 |
OCEA -1.00 |
Liabilities to Equity | 0.76 | 5/18 | BPMC 2.83 |
APLS 2.80 |
ADPT 1.50 |
DNA 0.86 |
RPRX 0.76 |
BGNE 0.70 |
MDGL 0.38 |
ISEE 0.29 |
IOVA 0.28 |
MRTX 0.19 |
CVAC 0.18 |
IKNA 0.11 |
KNTE 0.09 |
DAWN 0.08 |
KRTX 0.07 |
RPHM 0.02 |
ASND 0.00 |
OCEA 0.00 |
ROA | 0.05 | 2/18 | CVAC 14% | RPRX 5% | BPMC -11% | BGNE -15% | DAWN -15% | APLS -28% | KRTX -32% | ASND -35% | ADPT -35% | ISEE -35% | IKNA -40% | IOVA -41% | DNA -44% | MDGL -48% | MRTX -63% | KNTE -64% | RPHM -72% | OCEA -2352% |
ROE | 0.08 | 4/18 | ASND 394% |
OCEA 27% |
CVAC 17% |
RPRX 8% |
DAWN -16% |
BGNE -25% |
KRTX -34% |
BPMC -41% |
IKNA -44% |
ISEE -45% |
IOVA -53% |
MDGL -67% |
KNTE -70% |
RPHM -74% |
MRTX -76% |
DNA -82% |
ADPT -87% |
APLS -105% |
Current Ratio | 2.31 | 12/18 | RPHM 42.60 |
KRTX 16.30 |
DAWN 13.25 |
KNTE 12.16 |
IKNA 10.10 |
CVAC 6.60 |
MRTX 6.17 |
IOVA 4.55 |
ISEE 4.50 |
MDGL 3.62 |
BGNE 2.43 |
RPRX 2.31 |
DNA 2.17 |
ADPT 1.67 |
APLS 1.36 |
BPMC 1.35 |
ASND 0.92 |
OCEA 0.01 |
Quick Ratio | 0.12 | 17/18 | RPRX 16.33 |
CVAC 6.76 |
BGNE -1.00 |
MRTX -1.00 |
IOVA -1.00 |
MDGL -1.00 |
BPMC -1.00 |
APLS -1.00 |
ASND -1.00 |
ADPT -1.00 |
ISEE -1.00 |
KRTX -1.00 |
KNTE -1.00 |
IKNA -1.00 |
RPHM -1.00 |
OCEA -1.00 |
DAWN -1.00 |
DNA -1.00 |
Long Term Debt to Equity | 0.00 | 14/18 | BPMC} 1.09 |
DNA} 0.56 |
APLS} 0.44 |
ADPT} 0.37 |
ISEE} 0.20 |
MDGL} 0.15 |
IOVA} 0.09 |
BGNE} 0.06 |
CVAC} 0.05 |
MRTX} 0.04 |
IKNA} 0.03 |
KRTX} 0.01 |
RPHM} 0.01 |
RPRX} 0.00 |
KNTE} 0.00 |
OCEA} 0.00 |
DAWN} 0.00 |
ASND} -3.45 |
Debt to Equity | 0.00 | 14/18 | BPMC 1.23 |
DNA 0.56 |
APLS 0.47 |
ADPT 0.41 |
BGNE 0.32 |
ISEE 0.20 |
IOVA 0.10 |
CVAC 0.06 |
IKNA 0.06 |
MRTX 0.05 |
KNTE 0.02 |
KRTX 0.01 |
RPHM 0.01 |
RPRX 0.00 |
MDGL 0.00 |
DAWN 0.00 |
OCEA -0.13 |
ASND -8.10 |
Burn Rate | -4.47 | 17/18 | DNA 8.30 |
BGNE 7.71 |
RPHM 6.58 |
APLS 6.27 |
ISEE 6.26 |
IKNA 3.97 |
KNTE 3.30 |
ASND 3.11 |
MDGL 2.08 |
IOVA 1.84 |
KRTX 1.61 |
MRTX 1.56 |
BPMC 1.10 |
ADPT 1.01 |
OCEA 0.00 |
CVAC -1.49 |
RPRX -4.47 |
DAWN -11.45 |
Cash to Cap | 0.07 | 11/18 | IKNA 0.75 |
CVAC 0.74 |
DNA 0.73 |
RPHM 0.59 |
KNTE 0.46 |
DAWN 0.34 |
BGNE 0.13 |
APLS 0.12 |
IOVA 0.10 |
ISEE 0.08 |
RPRX 0.07 |
ASND 0.07 |
MRTX 0.06 |
MDGL 0.03 |
ADPT 0.03 |
BPMC 0.01 |
KRTX 0.01 |
OCEA 0.00 |
CCR | 3.57 | 1/18 | RPRX 3.57 |
ASND 2.28 |
DNA 2.10 |
CVAC 1.04 |
KNTE 1.02 |
KRTX 0.98 |
MRTX 0.89 |
IKNA 0.87 |
ADPT 0.85 |
IOVA 0.73 |
ISEE 0.72 |
MDGL 0.59 |
BPMC 0.24 |
OCEA 0.16 |
RPHM 0.00 |
DAWN -0.13 |
BGNE -0.45 |
APLS -0.59 |
EV to EBITDA | 36.17 | 1/18 | RPRX} 36.17 |
DAWN} 27.54 |
CVAC} 1.04 |
ISEE} -1.00 |
KNTE} -1.00 |
OCEA} -1.00 |
IKNA} -1.87 |
RPHM} -4.04 |
DNA} -12.25 |
IOVA} -18.09 |
MRTX} -22.72 |
ADPT} -39.32 |
APLS} -46.24 |
MDGL} -69.16 |
KRTX} -96.25 |
BPMC} -188.79 |
ASND} -257.89 |
BGNE} -379.98 |
EV to Revenue | 5.78 | 11/18 | KRTX 19006.33 |
MRTX 102.36 |
MDGL 92.73 |
IKNA 35.19 |
RPHM 35.00 |
DAWN 28.32 |
ASND 24.44 |
IOVA 17.74 |
BPMC 14.50 |
ADPT 7.24 |
RPRX 5.78 |
BGNE 5.61 |
APLS 4.62 |
DNA 3.10 |
CVAC 0.65 |
ISEE -1.00 |
KNTE -1.00 |
OCEA -1.00 |